Title: Clinical Observation on Modified BanXia BaiZhu TianMaTang for Hypertension LVH
Abstract: Objective: To observe clinical effects and the safety of modified BanXia BaiZhu TianMaTang in the treatment for hypertension left ventricular hypertrophy(LVH). Method: All 93 patients were randomized into 47cases in the treatment group and 46 cases in the control group. The control group took candesartan cilexetil tablets, 4to 8 mg each time, twice per day. The treatment group were administered with modified BanXia BaiZhu TianMa Tang, one dose per day, three times one day. Two months were one course of treatment, blood pressure, clinical symptoms and the indexes of LVH were investigated before and after treating in three courses of treatment, as well routine blood test, routine urine test and routine stool test, liver and kidney functions, at the same time, adverse reactions were recorded. Result: Average decrease of blood pressure in the treatment group was 10/6 mmHg, it had no statistical meaning compared with that in the control group(P 0.05). The results of ultrasound cardiogram showed that there were 13 cases markedly effective, 28 cases effective, total effective rate of the treatment group was87.23%; there were 11 cases remarkably effective, 22 cases effective, total effective rate 71.74%. The difference had statistical meaning in total effective rate between both groups(P0.05). The treatment group was superior to the control group notably in vertigo, headache, chest stuffiness and short of breath, which demonstrated the advantages of syndrome differentiation and treatment(P 0.05). There was no obvious adverse reaction in the course of treatment. Conclusion: Modified BanXia BaiZhu TianMaTang could improve clinical symptoms and LVH of the patients significantly, it is helpful to decrease blood pressure.
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot